Communiqués Arcus Biosciences, Inc.

Actions

RCUS

US03969F1093

Recherche biotechnologique et médicale

Marché Fermé - NYSE Autres places de cotation 22:00:03 02/07/2026			Varia. 5j.	Varia. 1 janv.
30,33 ^USD	+4,88%		-2,16%	+27,28%

24/06	Arcus Biosciences : un initié a cédé pour 877 501 dollars d’actions, selon un récent dépôt auprès de la SEC	MT
10/06	Transcript : Arcus Biosciences, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 10:40 AM

Communiqués

01/07	New Research Published in Nature Links Clinical Activity with HIF‑2a Biology in Advanced Kidney Cancer Patients Treated with Casdatifan	BU
24/06	Arcus Biosciences Announces New Employment Inducement Grants	BU
09/06	Arcus Biosciences Announces New Employment Inducement Grants	BU
04/06	Arcus Biosciences Announces Clinical Trial Collaboration and Supply Agreement to Evaluate Casdatifan in Combination with PD-L1/VEGF-A Bispecific Immunomodulator to Treat Kidney Cancer	AQ
03/06	Arcus Biosciences Announces Clinical Trial Collaboration and Supply Agreement to Evaluate Casdatifan in Combination with PD‑L1/VEGF‑A Bispecific Immunomodulator to Treat Kidney Cancer	BU
26/05	Arcus Biosciences to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference	BU
06/05	Arcus Biosciences : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)	PU
05/05	Arcus Biosciences : Reports First-Quarter 2026 Financial Results and Provides a Pi...	PU
05/05	Arcus Biosciences Reports First-Quarter 2026 Financial Results and Provides a Pipeline Update	BU
27/04	Arcus Biosciences Announces New Employment Inducement Grants	AQ
24/04	Arcus Biosciences Announces New Employment Inducement Grants	BU
21/04	Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2026 Financial Results and Pipeline Updates	BU
21/04	Arcus Biosciences : to Host Conference Call to Discuss First-Quarter 2026 Financia...	PU
09/04	Arcus Biosciences Announces New Employment Inducement Grants	BU
24/03	Arcus Biosciences Announces New Employment Inducement Grants	BU
09/03	Arcus Biosciences Announces New Employment Inducement Grants	BU
26/02	Arcus Biosciences to Participate in Two Upcoming Investor Conferences	BU
25/02	Arcus Biosciences : Reports Fourth-Quarter and Full-Year 2025 Financial Results an...	PU
25/02	Arcus Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides a Pipeline Update	BU
23/02	Arcus Presents New Data for its HIF-2a Inhibitor Casdatifan, Which Showed Progression-Free Survival Beyond One Year in Late-Line Kidney Cancer	BU
11/02	Arcus Biosciences : to Host Conference Call to Discuss Fourth-Quarter and Full-Yea...	PU
11/02	Arcus Biosciences to Host Conference Call to Discuss Fourth-Quarter and Full-Year 2025 Financial Results and Pipeline Updates	BU
26/01	Arcus Biosciences Announces New Employment Inducement Grants	BU
07/01	Arcus Outlines 2026 Plans for Casdatifan, its Potential Best-in-Class HIF-2a Inhibitor, and its Inflammation Programs	BU
18/12	Arcus Biosciences : to Participate in the 44th Annual J.P. Morgan Healthcare Confe...	PU